Acute bacterial meningitis in infants and children: epidemiology and management [0.03%]
婴儿和儿童急性细菌性脑膜炎的流行病学和治疗措施
Shruti Agrawal,Simon Nadel
Shruti Agrawal
Acute bacterial meningitis (ABM) continues to be associated with high mortality and morbidity, despite advances in antimicrobial therapy. The causative organism varies with age, immune function, immunization status, and geographic region, a...
Acute bacterial meningitis in infants and children: epidemiology and management [0.03%]
婴儿及儿童急性细菌性脑膜炎的流行病学和治疗措施
Shruti Agrawal,Simon Nadel
Shruti Agrawal
Acute bacterial meningitis (ABM) continues to be associated with high mortality and morbidity, despite advances in antimicrobial therapy. The causative organism varies with age, immune function, immunization status, and geographic region, a...
Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations [0.03%]
儿童慢性肝病的医疗管理（第2部分）：以慢性肝病并发症及需特别考虑的慢性肝病为重点
Mortada H F El-Shabrawi,Naglaa M Kamal
Mortada H F El-Shabrawi
Treatment of the causes of many chronic liver diseases (CLDs) may not be possible. In this case, complications must be anticipated, prevented or at least controlled by the best available therapeutic modalities. There are three main goals fo...
Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases [0.03%]
儿童慢性肝病的内科治疗（一）：可治愈或可能治愈性疾病
Mortada H F El-Shabrawi,Naglaa M Kamal
Mortada H F El-Shabrawi
The management of children with chronic liver disease (CLD) mandates a multidisciplinary approach. CLDs can be classified into 'potentially' curable, treatable non-curable, and end-stage diseases. Goals pertaining to the management of CLDs ...
Pediatric drug-resistant tuberculosis: a global perspective: a global perspective [0.03%]
儿童耐药结核病：全球性透视
Gary Reubenson
Gary Reubenson
This article was based on a presentation given at the 26th International Pediatric Association Conference of Pediatrics, Johannesburg, South Africa, 4-9 August 2010. In 2009, there were 9.4 million new cases of tuberculosis (TB) globally, a...
Pediatric drug-resistant tuberculosis: a global perspective: a global perspective [0.03%]
儿童耐药结核病：全球视角
Gary Reubenson
Gary Reubenson
This article was based on a presentation given at the 26th International Pediatric Association Conference of Pediatrics, Johannesburg, South Africa, 4-9 August 2010. In 2009, there were 9.4 million new cases of tuberculosis (TB) globally, a...
Antje Neubert
Antje Neubert
17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth [0.03%]
17α-羟基黄体酮己酸酯（Makena™）：预防早产
Emma D Deeks
Emma D Deeks
17 α-hydroxyprogesterone caproate is a synthetic progestin of which there is now a US FDA-approved formulation available for intramuscular administration (Makena™) to reduce the risk of preterm birth. Intramuscular 17 α-hydroxyprogestero...
Clonidine extended-release: in attention-deficit hyperactivity disorder [0.03%]
克隆迪宁缓释制剂在注意缺陷多动障碍中的应用
Jamie D Croxtall
Jamie D Croxtall
Clonidine, an α(2)-adrenergic agonist, is approved in the US as an extended-release (XR) tablet for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents (aged 6-17 years). In two, randomized, double-...